Teresa Caballero-Velazquez at Universidad de Sevilla - Research Interests, Publications & Academic Profile

Teresa Caballero-Velazquez

Profesor Contratado Doctor Vinculada

Universidad de Sevilla

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

90%

Biostatistics

50%

Hematology

100%

Graft-versus-host Disease

60%

Cancer Biology

40%

Flow Cytometry

30%

Lymphoma

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Monocytosis as prognostic factor for chronic graft versus host disease

Article Link

Year:

2024

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions

Article Link

Year:

2024

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring (Front. Immunol., (2024), 14, 1280580, 10.3389/fimmu.2023.1280580)

Article Link

Year:

2024

Hematological Neoplasms with Eosinophilia

Article Link

Year:

2024

Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials

Article Link

Year:

2023

Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study

Article Link

Year:

2023

Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

Article Link

Year:

2023

Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies

Article Link

Year:

2023

Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice

Article Link

Year:

2023

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment.

Article Link

Year:

2022

The incidental detection of clonal haemopoiesis of indeterminate potential with del(5q).

Article Link

Year:

2022

Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1.

Article Link

Year:

2022

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib

Article Link

Year:

2022

Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease

Article Link

Year:

2021

Auer rod-like inclusions in cerebrospinal fluid in accelerated phase chronic lymphocytic leukaemia.

Article Link

Year:

2021

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.

Article Link

Year:

2021

High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia

Article Link

Year:

2020

ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.

Article Link

Year:

2020

Collaborators3

Rosario M. Morales‐Camacho

SPAIN

JAIME PEREZ DE OTEYZA

HEAD

SPAIN

José Antonio Pérez-Simón

Universidad de Sevilla

SPAIN

How do Indian students reach out?

Meet Kite AI